MedPath

四川省通园制药集团有限公司

Ownership
-
Established
2002-02-09
Employees
-
Market Cap
-
Website
www.sctyzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

122

NMPA:122

Drug Approvals

Potassium Sodium Hydrogen Citrate Granules

Product Name
枸橼酸氢钾钠颗粒
Approval Number
国药准字H20244175
Approval Date
Jun 28, 2024
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20243120
Approval Date
Jan 30, 2024
NMPA

引阳索胶囊

Approval Number
国药准字Z20080094
Approval Date
Nov 30, 2023
NMPA

积雪苷胶囊

Approval Number
国药准字Z20090273
Approval Date
Nov 30, 2023
NMPA

通脉片

Approval Number
国药准字Z20090264
Approval Date
Nov 30, 2023
NMPA

复方岗松洗液

Approval Number
国药准字Z20194012
Approval Date
Nov 30, 2023
NMPA

新生化颗粒

Approval Number
国药准字Z20083418
Approval Date
Nov 30, 2023
NMPA

养阴降糖颗粒

Approval Number
国药准字Z20090278
Approval Date
Nov 30, 2023
NMPA

阿胶益寿口服液

Approval Number
国药准字Z20093160
Approval Date
Nov 30, 2023
NMPA

清宫长春片

Approval Number
国药准字Z20090298
Approval Date
Nov 30, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 13
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy